Medication Fact Sheet: Donald Trump (2026)

Save article

[favorite_button post_id="" site_id=""]

Pharmacy, medicine and box with healthcare shop, shelf and prescription care pills.

This is how the AI article summary could look. Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.

💊 Medication Fact Sheet: Donald Trump (2026)

Here is a comprehensive medication fact sheet for Donald Trump, based on his official 2025 and 2026 medical disclosures released by Physician to the President, Captain Sean Barbabella, D.O.

This summary outlines the primary medications used by the President to manage his cardiovascular health, dermatological conditions, and physical appearance.

1. Cardiovascular & Metabolic Health

These medications are the cornerstone of the President’s longevity strategy, aimed at maintaining his exceptionally low LDL cholesterol and reducing stroke risk.

Medication	Typical Dosage	Primary Purpose	Clinical Note
Rosuvastatin (Crestor)	10–40 mg	Lowering LDL Cholesterol	Contributes to his 2025 LDL level of 51 mg/dL.
Ezetimibe (Zetia)	10 mg	Inhibiting Cholesterol Absorption	Used in combination with a statin for intensive lipid control.
Aspirin	325 mg	Cardiac Prevention	Taken at a high dose for “blood thinning.” This is the documented cause of hand bruising.

2. Dermatological & Cosmetic Management

The President uses a mix of oral and topical treatments to manage chronic skin inflammation and maintain his signature hair.

Medication	Form	Primary Purpose	Clinical Note
Finasteride (Propecia)	Oral Tablet	Male Pattern Hair Loss	Originally prescribed by Dr. Bornstein; continued in 2026 to maintain hair density.
Tetracycline / Doxycycline	Oral (Low Dose)	Rosacea Management	Used for its anti-inflammatory properties rather than as an antibiotic.
Mometasone Cream	Topical	Skin Inflammation	Applied “as needed” to treat flare-ups of rosacea or actinic keratosis.

3. Key Medical Context (2025–2026 Updates)

The “Aspirin Bruise”: Public scrutiny often falls on purple patches on the President’s hands. His 2026 medical summary explicitly attributes this to “minor soft tissue irritation from frequent handshaking” exacerbated by his 325 mg daily aspirin regimen.
Venous Health: While not a medication, the President was diagnosed with Chronic Venous Insufficiency (CVI) in July 2025. His treatment plan focuses on conservative management (leg elevation) rather than additional prescriptions.
Cognitive Standing: His medical team continues to cite a 30/30 MoCA score as evidence that his current medication regimen has no adverse effect on his cognitive “sharpness.”

Note on “TrumpRx”: In 2026, many of the drugs the President takes (like Rosuvastatin and Zepbound for weight management in other patients) became part of the TrumpRx.gov initiative, which aims to provide these medications at “Most-Favored-Nation” pricing for the public.